ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00476827
Brief Title: A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

First Submitted : May 18, 2007
First Submitted that Met QC Criteria : May 21, 2007
First Posted : May 22, 2007 (Estimate)

Results First Submitted : December 10, 2012
Results First Submitted that Met QC Criteria : July 15, 2013
Results First Posted : July 17, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 15, 2013
Last Update Posted : July 17, 2013 (Estimate)